Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Presbyterian Hospital of Dallas |
---|---|
Information provided by: | Presbyterian Hospital of Dallas |
ClinicalTrials.gov Identifier: | NCT00279487 |
The purpose of this study is to determine whether gabapentin, as a one time administration prior to a total knee replacement procedure, has opioid sparing effects and a reduction in pain scores.
Condition | Intervention |
---|---|
Pain |
Drug: Gabapentin |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Placebo Control, Single Group Assignment |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Patients undergoing total knee replacement who received pain management by the following modality:
Exclusion Criteria:
Contact: Rob Hutchison, PharmD | 214-345-2493 | robhutchison@texashealth.org |
United States, Texas | |
Presbyterian Hospital of Dallas | Recruiting |
Dallas, Texas, United States, 75231 | |
Contact: Rob Hutchison 214-345-2493 robhutchison@texashealth.org | |
Contact: Denise Stamos 214-345-2966 denisestamos@texashealth.org | |
Principal Investigator: William Tucker | |
Sub-Investigator: Jeffrey Pirinelli | |
Sub-Investigator: Joy Aguwa |
Principal Investigator: | Rob Hutchison | Presbyterian Hospital of Dallas |
Study ID Numbers: | P768 |
Study First Received: | January 16, 2006 |
Last Updated: | February 27, 2007 |
ClinicalTrials.gov Identifier: | NCT00279487 |
Health Authority: | United States: Institutional Review Board |
Patients undergoing total knee replacement who received pain management by the following modality: IV PCA opioid Local femoral nerve block with 1.5% Mepivacaine & 0.5% Ropivacaine |
Mepivacaine Excitatory Amino Acids Calcium, Dietary |
Ropivacaine Gabapentin Pain |
Neurotransmitter Agents Tranquilizing Agents Molecular Mechanisms of Pharmacological Action Anti-Dyskinesia Agents Physiological Effects of Drugs Psychotropic Drugs Central Nervous System Depressants Antiparkinson Agents Calcium Channel Blockers Excitatory Amino Acid Agents Cardiovascular Agents |
Antimanic Agents Pharmacologic Actions Membrane Transport Modulators Sensory System Agents Therapeutic Uses Anti-Anxiety Agents Analgesics Peripheral Nervous System Agents Central Nervous System Agents Anticonvulsants Excitatory Amino Acid Antagonists |